US · Healthcare

CardioGenics Holdings Inc (CGNH)

Diagnostics & Research

CardioGenics Holdings Inc (CGNH) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CGNH

P/E ratio

18.00

CardioGenics Holdings Inc (CGNH) — FAQ

What is CGNH's P/E ratio?

The price-to-earnings (P/E) ratio for CardioGenics Holdings Inc (CGNH) is 18.00 (data as of 2026-03-23).

Does CardioGenics Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for CardioGenics Holdings Inc (CGNH). Check the MyAverix Finance app for the latest dividend data.

What sector is CardioGenics Holdings Inc in?

CardioGenics Holdings Inc (CGNH) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is CGNH listed on?

CGNH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)